INSIGHTS ON LIQUID DOSE MANUFACTURING

• Empowering Innovation: Harnessing CDMO Potential For Sterile Injectables

  Specialized CDMOs are essential for meeting the growing demand and complex quality requirements for sterile injectables. Outsourcing provides crucial benefits like cost savings, flexibility, and a strategic focus on core competencies.

• Driving Excellence In Aseptic Fill-Finish: A Strategic Partnership With Stäubli Robotics

  See how intelligent automation and purpose-built robotics deliver contamination control and operational excellence in demanding sterile manufacturing environments.

• Raise Your Standards With Downflow Booth Airflow Containment

  Ensure personnel safety during hazardous material handling by mastering airflow dynamics and containment screens. Learn to achieve low exposure levels through advanced HEPA filtration methods.

• Isolators For Pharmacy Compounding – Time For Change?

  Maintaining a contamination-free environment is crucial in drug compounding. Learn how isolator systems can improve safety, efficiency, and regulatory compliance.

• NanoImprove The Performance Of Your Formulations

  9/24/2024

  Learn how Nanoforming can help improve the performance of your molecule by increasing drug loads, improving bioavailability, enhancing drug delivery profiles, and supporting product differentiation.

• Quality Assurance In Pharmaceutical Water For Injection (WFI) Systems

  3/19/2026

  Maintaining the integrity of Water for Injection (WFI) systems is a non-negotiable priority in pharmaceutical manufacturing. Watch this webinar to refine your contamination control strategies.

• A Universal Workflow Approach For Single Cell Mass Spectrometry Based Proteomics

  11/7/2025

  Learn about a streamlined workflow that improves reproducibility, reduces contamination, and simplifies single-cell proteomics with comparable results to FACS.

• Bridging The Gap Between Product Readiness And Equipment Availability

  12/15/2025

  Discover how manual precision at scale bridges packaging gaps, accelerates product launches, and ensures uninterrupted supply to deliver quality when automated equipment isn’t yet operational.

• De-Risking The Transition From Vial To Drug-Device Combination Product

  7/25/2025

  When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.